CEO Hugh Sheridan

Member Article

Mersey medical tech firm hits £11 million turnover after international success

Mersey medical technology company ALG International Holdings says international expansion will form a key part of its future growth plans, as its offices abroad post impressive revenue growth.

ALG International Holdings achieved turnover of £11million in 2014, up from £10.7million in the previous year.

Its offices in Los Angeles and Dubai saw year-on-year revenue increases of 54% and 48% respectively. Its Melbourne office reported 20% growth.

ALG owns and operates eight medical product brands covering orthotics and prosthetics, podiatry and physiotherapy and rehabilitation.

These include Diaped, the leading diabetic foot brand, Podotech and Slimflex, which provide foot care specialists with a range of innovative products, and Aortha, offering the latest material technology for use within the orthotics and prosthetics sector.

ALG also operates Algeos, its global distribution brand, which currently supplies products to more than 70 countries.

During the past 12 months, ALG has increased its staff headcount from 81 to 94.

ALG is headquartered in Speke, Merseyside, and is led by CEO Hugh Sheridan.

Hugh said: “ALG has built a reputation not only as a provider of industry-leading medical products, but increasingly as a leader in innovation and technology.

“We are excited by the future potential not only in the UK but also overseas where our offices in Australia, the United States and the United Arab Emirates are seeing substantial year-on-year growth.

“ALG will continue to develop and bring to market life-changing products that not only change the way people move, but also the way they feel.”

In addition to its product brands and distribution arm, ALG also continually invests in the research and development of existing and new products.

This was posted in Bdaily's Members' News section by Clare Burnett .

Explore these topics

Our Partners